Mark Wiggins, Senior Vice President, Business Development
Mr. Wiggins joined Elcelyx in July 2012 as Sr. VP Business Development. Formerly he served as the Chief Business Officer of Mpex Pharmaceuticals overseeing strategic business operations of the company until the sale of Mpex to Aptalis in 2011. Prior to Mpex, Mr. Wiggins served as Executive Vice President, Corporate and Business Development of Biogen Idec, Inc. for five years. In this position, he was responsible for worldwide partnering, licensing and corporate acquisitions. During his time in this role Biogen-Idec completed approximately 20 significant transactions including the purchase of three private companies. Prior to Biogen’s merger with Idec Pharmaceuticals in 2003, Mr. Wiggins was the Vice President of Marketing and Business Development at Idec for six years, serving on the management committee for the collaboration with Genentech on Rituxan®. Mr. Wiggins worked for several premier pharmaceutical companies in the commercial area for the first fifteen years of his career. Mr.Wiggins has served as a member the Zogenix board of directors since May 2011.
Mr.Wiggins received his B.S. degree in Finance from Syracuse University and an M.B.A. from the University of Arizona.